Literature DB >> 31661684

A Novel Pathogenic Variant in the CABP2 Gene Causes Severe Nonsyndromic Hearing Loss in a Consanguineous Iranian Family.

Mahbobeh Koohiyan1,2, Mohammad Reza Noori-Daloii3, Morteza Hashemzadeh-Chaleshtori4, Mansoor Salehi1, Hamidreza Abtahi5, Mohammad Amin Tabatabaiefar6,7.   

Abstract

BACKGROUND AND OBJECTIVES: Hereditary hearing loss (HL) can originate from mutations in one of many genes involved in the complex process of hearing. CABP2 mutations have been reported to cause moderate HL. Here, we report the whole exome sequencing (WES) of a proband presenting with prelingual, severe HL in an Iranian family.
METHODS: A comprehensive family history was obtained, and clinical evaluations and pedigree analysis were performed in the family with 2 affected members. After excluding mutations in the GJB2 gene and 7 other most common autosomal recessive nonsyndromic HL (ARNSHL) genes via Sanger sequencing and genetic linkage analysis in the family, WES was utilized to find the possible etiology of the disease.
RESULTS: WES results showed a novel rare variant (c.311G>A) in the CABP2gene.This missense variant in the exon 4 of the CABP2gene meets the criteria of being pathogenic according to the American College of Medical Genetics and Genomics (ACMG) interpretation guidelines.
CONCLUSIONS: Up to now, 3 mutations have been reported for the CABP2gene to cause moderate ARNSHL in different populations. Our results show that CABP2variantsalso cause severe ARNSHL, adding CABP2to the growing list of genes that exhibit phenotypic heterogeneity. Expanding our understanding of the mutational spectrum of HL genes is an important step in providing the correct clinical molecular interpretation and diagnosis for patients.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  American College of Medical Genetics and Genomics guideline; Autosomal recessive nonsyndromic hearing loss; CABP2; Genetic linkage analysis; Whole exome sequencing

Year:  2019        PMID: 31661684     DOI: 10.1159/000502251

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  2 in total

1.  First reported CABP2-related non-syndromic hearing loss in Northern Europe.

Authors:  Inger Norlyk Sheyanth; Allan Thomas Højland; Henrik Okkels; Ihab Lolas; Christian Thorup; Michael Bjørn Petersen
Journal:  Mol Genet Genomic Med       Date:  2021-03-05       Impact factor: 2.183

2.  Autosomal recessive nonsyndromic hearing impairment in two Finnish families due to the population enriched CABP2 c.637+1G>T variant.

Authors:  Thashi Bharadwaj; Isabelle Schrauwen; Anushree Acharya; Liz M Nouel-Saied; Marja-Leena Väisänen; Minna Kraatari; Elisa Rahikkala; Irma Jarvela; Jouko Kotimäki; Suzanne M Leal
Journal:  Mol Genet Genomic Med       Date:  2022-02-11       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.